A small research company developing a promising treatment for multiple sclerosis has won a prestigious award to pay for further research.
Cognosci will use the $330,000 grant to continue evaluating an experimental compound that shows potential in helping rebuild the central nervous system, rather than just blocking damage from MS.................Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397